Justin Bowers
Stock Analyst at Deutsche Bank
(3.44)
# 869
Out of 4,479 analysts
39
Total ratings
43.33%
Success rate
6.7%
Average return
Main Sectors:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $120.14 | +29.02% | 2 | Jun 26, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $36 → $28 | $23.80 | +17.65% | 2 | May 23, 2024 | |
| TMO Thermo Fisher | Maintains: Buy | $600 → $610 | $533.93 | +14.25% | 3 | Apr 25, 2024 | |
| TXG 10x Genomics | Maintains: Buy | $60 → $55 | $18.87 | +191.47% | 2 | Apr 18, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $71.24 | +15.10% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Maintains: Hold | $23 → $25 | $20.58 | +21.48% | 3 | Apr 18, 2024 | |
| MEDP Medpace Holdings | Initiates: Hold | $395 | $404.42 | -2.33% | 1 | Mar 18, 2024 | |
| CTLT Catalent | Maintains: Hold | $37 → $45 | $56.20 | -19.93% | 8 | Aug 15, 2023 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $23 → $17 | $6.84 | +148.54% | 3 | Aug 8, 2023 | |
| ICLR ICON PLC | Maintains: Buy | $280 → $300 | $318.30 | -5.75% | 2 | Jul 14, 2023 | |
| DHR Danaher | Maintains: Buy | $310 → $275 | $240.41 | +14.39% | 2 | Apr 27, 2023 | |
| WAT Waters | Initiates: Hold | $350 | $284.49 | +23.03% | 1 | Dec 14, 2022 | |
| WST West Pharmaceutical Services | Initiates: Hold | $250 | $322.60 | -22.50% | 1 | Dec 14, 2022 | |
| AMED Amedisys | Maintains: Buy | $175 → $165 | $96.74 | +70.56% | 3 | Oct 24, 2022 | |
| CRL Charles River Laboratories International | Maintains: Buy | $350 → $290 | $201.48 | +43.93% | 1 | Jul 14, 2022 | |
| IQV IQVIA Holdings | Maintains: Buy | $250 → $290 | $207.47 | +39.78% | 1 | Apr 12, 2022 | |
| SEM Select Medical Holdings | Maintains: Buy | n/a | $36.16 | - | 2 | Apr 24, 2020 |
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $120.14
Upside: +29.02%
Fortrea Holdings
May 23, 2024
Maintains: Hold
Price Target: $36 → $28
Current: $23.80
Upside: +17.65%
Thermo Fisher
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $533.93
Upside: +14.25%
10x Genomics
Apr 18, 2024
Maintains: Buy
Price Target: $60 → $55
Current: $18.87
Upside: +191.47%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $71.24
Upside: +15.10%
Avantor
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $20.58
Upside: +21.48%
Medpace Holdings
Mar 18, 2024
Initiates: Hold
Price Target: $395
Current: $404.42
Upside: -2.33%
Catalent
Aug 15, 2023
Maintains: Hold
Price Target: $37 → $45
Current: $56.20
Upside: -19.93%
Maravai LifeSciences Holdings
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $6.84
Upside: +148.54%
ICON PLC
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $318.30
Upside: -5.75%
Danaher
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $240.41
Upside: +14.39%
Waters
Dec 14, 2022
Initiates: Hold
Price Target: $350
Current: $284.49
Upside: +23.03%
West Pharmaceutical Services
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $322.60
Upside: -22.50%
Amedisys
Oct 24, 2022
Maintains: Buy
Price Target: $175 → $165
Current: $96.74
Upside: +70.56%
Charles River Laboratories International
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $201.48
Upside: +43.93%
IQVIA Holdings
Apr 12, 2022
Maintains: Buy
Price Target: $250 → $290
Current: $207.47
Upside: +39.78%
Select Medical Holdings
Apr 24, 2020
Maintains: Buy
Price Target: n/a
Current: $36.16
Upside: -